Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma

Seminars in Oncology

Volumn 24, Issue 2 SUPPL. 6, 1997, Pages

  Yoshioka, H ^a   Sato, M ^a   Sonomura, T ^a   Terada, M ^a   Kishi, K ^a   Yoshikawa, A ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CONTRAST MEDIUM; DOXORUBICIN; GELATIN SPONGE; MITOMYCIN C;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; CANCER INVASION; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; LIVER; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PORTAL VEIN; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PORTAL VEIN; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031005719     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)